Market Cap N/A
Revenue (ttm) 34.16M
Net Income (ttm) -50.62M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 1,363
Avg Vol 56,854
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 85%
Beta N/A
Analysts Strong Sell
Price Target N/A

Company Profile

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems...

Phone: 510 250 7800
Address:
5980 Horton Street, Suite 600, Emeryville, United States
Latest News on OABIW
OmniAb to Hold OmniUltra Virtual Investor Event on December 15

Dec 4, 2025, 4:05 PM EST - 4 months ago

OmniAb to Hold OmniUltra Virtual Investor Event on December 15


OmniAb to Participate in Three Investor Conferences in November

Oct 16, 2025, 8:00 AM EDT - 6 months ago

OmniAb to Participate in Three Investor Conferences in November


OmniAb Announces $30 Million Private Placement

Aug 25, 2025, 7:00 AM EDT - 8 months ago

OmniAb Announces $30 Million Private Placement


OmniAb Introduces the xPloration® Partner Access Program

May 8, 2025, 4:05 PM EDT - 1 year ago

OmniAb Introduces the xPloration® Partner Access Program


OmniAb to Participate in Five Upcoming Investor Conferences

May 1, 2025, 8:00 AM EDT - 1 year ago

OmniAb to Participate in Five Upcoming Investor Conferences


OmniAb to Participate in Two Investor Conferences in March

Feb 3, 2025, 4:57 PM EST - 1 year ago

OmniAb to Participate in Two Investor Conferences in March


OmniAb to Participate in Two Investor Conferences in November

Oct 30, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Participate in Two Investor Conferences in November


OmniAb to Participate in Five Investor Conferences in May

May 1, 2024, 8:00 AM EDT - 2 years ago

OmniAb to Participate in Five Investor Conferences in May


OmniAb to Report First Quarter 2024 Financial Results on May 9

Apr 22, 2024, 8:00 AM EDT - 2 years ago

OmniAb to Report First Quarter 2024 Financial Results on May 9


OmniAb Appoints Steve Love to its Board of Directors

Nov 1, 2023, 9:00 AM EDT - 2 years ago

OmniAb Appoints Steve Love to its Board of Directors


OmniAb Announces the Passing of Director Sunil Patel

Aug 7, 2023, 4:05 PM EDT - 2 years ago

OmniAb Announces the Passing of Director Sunil Patel